Managed Healthcare Executive March 12, 2025
Denise Myshko

The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to increase transparency in drug pricing.

Several weeks after the House Committee on Energy and Commerce’s Subcommittee on Health held a hearing to discuss creating competition in the pharmacy benefit manager industry, several senators have introduced a bipartisan bill that would limit PBMs’ spread pricing at pharmacies used by Medicaid beneficiaries.

Senators Peter Welch, a Democrat from Vermont, Roger Marshall, a Republican from Kansas, Mark Warner, a Democrat from Virginia, and Bill Cassidy, a Republican from Louisiana, have introduced the Protecting Pharmacies in Medicaid Act, which would require Medicaid’s payments to PBMs to be passed directly to pharmacies, excluding administrative...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Insurance, Medicaid, Pharma, Pharma / Biotech
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity
Ono pays $280M to license Ionis rare disease drug

Share This Article